Cypherpunk Technologies Inc.
CYPH Nasdaq Pharmaceutical Preparations Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$2.82
5.4%What Cypherpunk Technologies Inc. does
No business description yet.
- Legal name
- CYPHERPUNK TECHNOLOGIES INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 16, 2026
- Accession ยท CIK
- 0001104659-26-028566
0001509745
Revenue and margins
Cypherpunk Technologies Inc. had โ of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cypherpunk Technologies Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 88.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cypherpunk Technologies Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $115M | $65.5M | $70.6M | $47.2M | $14.0M |
| Interest coverage | โ1,010.4x | โ1,051.2x | โ | โ | โ1,711.1x |
| Current ratio | 11.7x | 6.1x | 5.6x | 3.4x | 35.6x |
| Quick ratio | 11.7x | 6.1x | 5.6x | 3.4x | 35.6x |
| Total assets | $118M | $70.4M | $72.8M | $49.1M | $163M |
| Total liabilities | $10.0M | $11.5M | $12.7M | $14.1M | $9.7M |
| Shareholders' equity | $108M | $58.9M | $60.1M | $35.0M | $154M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | โ / 6 | โ / 6 | โ / 6 | 3 / 7 | โ / 6 | โ / 6 | โ / 6 | โ / 6 |
| Accruals ratio | โ4.6% | โ42.7% | 12.0% | โ45.2% | โ5.0% | โ6.3% | โ5.9% | โ52.6% | โ11.9% | 45.9% |
| Altman Z'' | โ114.79 | โ16.59 | โ32.36 | โ119.55 | โ5.13 | 7.60 | โ9.50 | โ15.63 | โ33.45 | 12.06 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | โ | โ | โ | โ | $1.5M | $1.5M | โ | โ | โ | โ |
| Research and development | $23.3M | $22.5M | $21.8M | $24.4M | $20.4M | $32.2M | $45.0M | $73.2M | $57.2M | $25.7M |
| Operating income | โ$27.3M | โ$32.4M | โ$30.8M | โ$33.5M | โ$28.5M | โ$41.4M | โ$56.8M | โ$87.0M | โ$70.1M | โ$41.1M |
| Interest expense | โ | $0.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | โ | โ | $0.0M |
| Pretax income | โ$25.6M | โ$29.9M | โ$23.1M | โ$32.9M | โ$27.5M | โ$40.6M | โ$54.4M | โ$81.4M | โ$67.0M | $10.1M |
| Income tax | โ | โ$0.2M | $0.0M | โ$0.0M | โ$0.0M | โ$0.0M | $0.1M | โ | $0.6M | $5.3M |
| Net income | โ$25.6M | โ$29.7M | โ$23.1M | โ$32.9M | โ$27.5M | โ$40.6M | โ$54.6M | โ$81.4M | โ$67.6M | $4.8M |
| Net income to common | โ | โ$30.0M | โ$23.1M | โ$33.3M | โ$37.6M | โ$40.6M | โ$54.6M | โ$81.4M | โ$67.8M | $4.8M |
| Diluted EPS | โ | โ$3.31 | โ$2.11 | โ$1.47 | โ$0.63 | โ$0.47 | โ$4.82 | โ$3.98 | โ$1.81 | $0.07 |
| Diluted shares | โ | 0.01B | 0.01B | 0.02B | 0.06B | 0.09B | 0.01B | 0.02B | 0.04B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | โ$25.3M | โ$22.1M | โ$26.0M | โ$26.9M | โ$26.0M | โ$35.2M | โ$49.0M | โ$43.8M | โ$60.3M | โ$43.9M |
| Capital expenditure | $0.1M | $0.1M | โ | $0.1M | โ | โ | โ | โ | โ | โ |
| Free cash flow | โ$25.5M | โ$22.2M | โ | โ$27.0M | โ | โ | โ | โ | โ | โ |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Stock-based compensation | $0.0M | $5.6M | $3.5M | $3.7M | $2.6M | $3.7M | $5.2M | $5.1M | $5.5M | $4.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.8M | $25.7M | $16.3M | $3.9M | $52.1M | $115M | $65.5M | $70.6M | $47.2M | $14.0M |
| Current assets | $4.0M | $27.7M | $17.3M | $4.2M | $52.3M | $117M | $68.0M | $71.6M | $48.0M | $162M |
| Current liabilities | $36.2M | $6.1M | $6.5M | $8.5M | $7.4M | $10.0M | $11.2M | $12.7M | $14.1M | $4.6M |
| Property and equipment, net | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | โ |
| Total assets | $6.5M | $29.1M | $19.1M | $7.4M | $54.4M | $118M | $70.4M | $72.8M | $49.1M | $163M |
| Total liabilities | $36.2M | $17.9M | $9.9M | $9.2M | $7.7M | $10.0M | $11.5M | $12.7M | $14.1M | $9.7M |
| Shareholders' equity | โ$100M | $11.1M | $9.2M | โ$1.7M | $46.7M | $108M | $58.9M | $60.1M | $35.0M | $154M |
| Margins | ||||||||||
| Operating margin | โ | โ | โ | โ | โ1,902.6% | โ2,761.7% | โ | โ | โ | โ |
| EBITDA margin | โ | โ | โ | โ | โ1,900.3% | โ2,759.8% | โ | โ | โ | โ |
| Net margin | โ | โ | โ | โ | โ1,834.3% | โ2,705.8% | โ | โ | โ | โ |
| Returns | ||||||||||
| Return on capital employed | 91.9% | โ140.8% | โ243.6% | 3,222.6% | โ60.7% | โ38.4% | โ96.0% | โ144.7% | โ199.9% | โ25.9% |
| Return on equity | โ | โ | โ228.1% | โ886.1% | โ122.6% | โ52.5% | โ65.5% | โ136.8% | โ141.9% | 5.1% |
| Return on assets | โ397.0% | โ167.4% | โ96.1% | โ248.1% | โ89.0% | โ47.1% | โ58.0% | โ113.7% | โ110.8% | 4.5% |
| Return on tangible equity | โ | โ269.6% | โ252.2% | โ | โ80.6% | โ37.6% | โ92.7% | โ135.4% | โ193.4% | 3.1% |
| Growth | ||||||||||
| Revenue growth | โ | โ | โ | โ | โ | 0.0% | โ | โ | โ | โ |
| Share count change | โ | โ | 56.9% | 56.7% | 162.7% | 44.7% | โ86.8% | 80.5% | 83.7% | 88.2% |
| Financial health | ||||||||||
| Interest coverage | โ | โ61.3x | โ1,618.5x | โ1,454.4x | โ731.8x | โ1,010.4x | โ1,051.2x | โ | โ | โ1,711.1x |
| Current ratio | 0.1x | 4.5x | 2.7x | 0.5x | 7.1x | 11.7x | 6.1x | 5.6x | 3.4x | 35.6x |
| Quick ratio | 0.1x | 4.5x | 2.7x | 0.5x | 7.1x | 11.7x | 6.1x | 5.6x | 3.4x | 35.6x |
| Capital allocation | ||||||||||
| Stock comp / revenue | โ | โ | โ | โ | 171.5% | 245.7% | โ | โ | โ | โ |
| Quality scores | ||||||||||
| Piotroski F-score | โ | โ | โ | โ | โ | 3.0 | โ | โ | โ | โ |
| Altman Z'' | โ114.8 | โ16.6 | โ32.4 | โ119.5 | โ5.1 | 7.6 | โ9.5 | โ15.6 | โ33.4 | 12.1 |
| Accruals ratio | โ4.6% | โ42.7% | 12.0% | โ45.2% | โ5.0% | โ6.3% | โ5.9% | โ52.6% | โ11.9% | 45.9% |
Source: SEC EDGAR XBRL filings (CIK 0001509745). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
